Nagaraj Shetti, a Senior Technical Research Analyst at HDFC Securities, has recently recommended buying shares of Poly Medicure and Oil India. Here's a breakdown of the recommendations:
Market Overview
The Indian stock market has shown stability after a period of losses. On September 25, 2025, the Nifty 50 was down by 0.29% to 24,983.15, and the BSE Sensex decreased by 0.33% to 81,494.12. Investor confidence has been affected by ongoing foreign investment withdrawals and new U.S. visa restrictions.
Nagaraj Shetti noted that the Nifty 50 is trading lower but hasn't seen a sharp selloff. He anticipates buying interest may emerge around the 24,900 level, which is a cluster support zone. A decisive move above 25,100-25,150 levels could confirm a bottom reversal pattern.
Poly Medicure
Poly Medicure is a small-cap company in the Hospitals & Allied Services sector. As of November 30, 2022, HDFC Securities had a buy call on Poly Medicure with a target price of Rs 1035, when the current market price was Rs 975.75. The analyst suggested placing a stop loss at Rs 945.
The stock price has been in an uptrend, forming higher tops and bottoms. As of September 30, 2022, promoters held 53.33% of the company's stake, FIIs owned 15.59%, and DIIs held 3.39%.
Oil India
While the specific details of the Oil India recommendation like target price and stop loss were not available in the provided context, Nagaraj Shetti has recommended it as a stock to buy alongside Poly Medicure.
Additional Market Insights
Nagaraj Shetti observed that the market has been in a continuous uptrend after breaking out of a range movement. He anticipates the Nifty to move towards 24,450 to 24,500 in the near term. He also noted that the banking sector, especially private and PSU banks, and the metal sector are likely to perform well in the near term.
Other Stock Recommendations
Besides Nagaraj Shetti's picks, other experts have also shared their recommendations:
Disclaimer: It's important to note that these recommendations are based on the analysts' own views and do not represent those of Mint. Investors should consult with certified experts before making any investment decisions.